Ke Zeng

850 total citations
34 papers, 642 citations indexed

About

Ke Zeng is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ke Zeng has authored 34 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Immunology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ke Zeng's work include interferon and immune responses (5 papers), Autophagy in Disease and Therapy (5 papers) and Pregnancy and preeclampsia studies (3 papers). Ke Zeng is often cited by papers focused on interferon and immune responses (5 papers), Autophagy in Disease and Therapy (5 papers) and Pregnancy and preeclampsia studies (3 papers). Ke Zeng collaborates with scholars based in China, New Zealand and United States. Ke Zeng's co-authors include Min Zhao, Shuguang Gao, Min‐Yu Tu, Guanghua Lei, Q Chen, Qi Chen, Yongxiang Yin, Mancy Tong, Arier Lee and Lili Dong and has published in prestigious journals such as Blood, Gut and Scientific Reports.

In The Last Decade

Ke Zeng

32 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Zeng China 15 228 156 140 129 103 34 642
Shelly Tartakover Matalon Israel 17 159 0.7× 89 0.6× 164 1.2× 120 0.9× 46 0.4× 31 645
Hai-Tao Yang China 14 177 0.8× 245 1.6× 212 1.5× 73 0.6× 149 1.4× 25 851
Raluca Bălan Romania 13 182 0.8× 114 0.7× 96 0.7× 43 0.3× 32 0.3× 56 686
Gertrud Unfried Austria 17 132 0.6× 325 2.1× 304 2.2× 93 0.7× 107 1.0× 28 944
Darius Dian Germany 19 250 1.1× 277 1.8× 208 1.5× 53 0.4× 36 0.3× 56 1.0k
Fangfang Dai China 18 357 1.6× 112 0.7× 222 1.6× 36 0.3× 44 0.4× 74 854
Shaida Ouladan Canada 8 187 0.8× 65 0.4× 58 0.4× 47 0.4× 45 0.4× 9 529
S Bjornsson United Kingdom 11 98 0.4× 357 2.3× 88 0.6× 148 1.1× 284 2.8× 22 736
Lucrezia Manente Italy 15 289 1.3× 106 0.7× 112 0.8× 14 0.1× 39 0.4× 26 597

Countries citing papers authored by Ke Zeng

Since Specialization
Citations

This map shows the geographic impact of Ke Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Zeng more than expected).

Fields of papers citing papers by Ke Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Zeng. The network helps show where Ke Zeng may publish in the future.

Co-authorship network of co-authors of Ke Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Zeng. A scholar is included among the top collaborators of Ke Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Zeng. Ke Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Huaji, Z. Hu, Jiansen Lu, et al.. (2025). VANGL2 alleviates inflammatory bowel disease by recruiting the ubiquitin ligase MARCH8 to limit NLRP3 inflammasome activation through OPTN-mediated selective autophagy. PLoS Biology. 23(2). e3002961–e3002961. 3 indexed citations
2.
Chen, Huimin, et al.. (2025). Interfacial engineering-tailored Mn-clay-based nanozyme for glyphosate laccase-amplified sensing and inhibitor screening. Biosensors and Bioelectronics. 287. 117672–117672. 1 indexed citations
4.
Lu, Jiansen, Zhiqiang Hu, Huaji Jiang, et al.. (2024). Dual nature of type I interferon responses and feedback regulations by SOCS1 dictate malaria mortality. Journal of Advanced Research. 73. 295–310. 1 indexed citations
5.
Wang, Yongheng, et al.. (2024). Biochemical hallmarks-targeting antineoplastic nanotherapeutics. Bioactive Materials. 36. 427–454. 8 indexed citations
6.
Jiang, Huaji, Jiansen Lu, Hongyu Li, et al.. (2023). Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy. Autophagy. 20(1). 76–93. 26 indexed citations
7.
Hu, Z., Jiansen Lu, Huaji Jiang, et al.. (2023). VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation. Science Advances. 9(25). eadg2339–eadg2339. 15 indexed citations
8.
Zeng, Ke, et al.. (2022). Bioinformatics analysis of key pathways and genes in osteosarcoma development. Panminerva Medica. 65(3). 401–402. 1 indexed citations
9.
Jiang, Yafei, Gangyang Wang, Haoran Mu, et al.. (2021). Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling. Frontiers in Oncology. 11. 642134–642134. 14 indexed citations
10.
Zeng, Ke, et al.. (2020). PAX3 silencing inhibits prostate cancer progression through the suppression of the TGF‐β/Smad signaling axis. Cell Biology International. 44(10). 2131–2139. 8 indexed citations
11.
Liu, Guodong, et al.. (2019). M2 Macrophages Promote HCC Cells Invasion and Migration via miR-149-5p/MMP9 Signaling. Journal of Cancer. 11(5). 1277–1287. 41 indexed citations
12.
Yang, Xiao, et al.. (2018). Expression of PD-L1/PD-L2 is associated with high proliferation index of Ki-67 but not with TP53 overexpression in chondrosarcoma. The International Journal of Biological Markers. 33(4). 507–513. 18 indexed citations
13.
Zhao, Min, et al.. (2016). The Reduction in Circulating Melatonin Level May Contribute to the Pathogenesis of Ovarian Cancer: A Retrospective Study. Journal of Cancer. 7(7). 831–836. 38 indexed citations
14.
Gao, Yifei, Ke Zeng, Yongxiang Yin, et al.. (2016). The levels of the sex hormones are not different between type 1 and type 2 endometrial cancer. Scientific Reports. 6(1). 39744–39744. 33 indexed citations
15.
Yang, Xiao, Yaping Wang, Fengxiang Liu, et al.. (2013). Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2. In Vitro Cellular & Developmental Biology - Animal. 49(4). 270–278. 21 indexed citations
16.
Yang, Xiao, Fengxiang Liu, Ke Zeng, et al.. (2013). Inhibition of mTOR and HIF pathways diminishes chondro-osteogenesis and cell proliferation in chondroblastoma. Tumor Biology. 34(5). 3111–3119. 2 indexed citations
17.
Zhao, Zhuoxian, Sheyu Li, Li Zhang, et al.. (2012). Dopamine D1 Receptor Gene Polymorphism Is Associated with Myocardial Infarction. DNA and Cell Biology. 31(6). 1010–1014. 1 indexed citations
18.
Bai, Yi, Siyue Li, Ke Zeng, et al.. (2011). Donor or recipient TNF-A −308G/A polymorphism and acute rejection of renal allograft: A meta-analysis. Transplant Immunology. 25(1). 61–71. 20 indexed citations
19.
Gao, Shuguang, et al.. (2009). Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthritis and Cartilage. 18(1). 82–87. 94 indexed citations
20.
Huang, Zhiqiang, Lili Dong, Yan Zhu, et al.. (2009). Targeting delivery of anti-TNF  oligonucleotide into activated colonic macrophages protects against experimental colitis. Gut. 59(4). 470–479. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026